SLB vs STRO
Schlumberger NV (SLB) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Schlumberger NV (SLB) is a oil & gas equipment & services company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported SLB revenue for 2025-12-31 was $35.71B. Net income was $3.37B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
SLB currently screens at market cap $48.16B and trailing P/E 12.1. STRO currently screens at market cap $470.8M.
Not investment advice. Open the SLB and STRO stock pages for the full models.
Not investment advice.